Man Group
MTEM

Man Group’s Molecular Templates, Inc. MTEM Stock Holding History

Man Group’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,706
Closed -$512K – 2435
2021
Q4 		$512K Buy
8,706
+1,594
+22% +$119K ﹤0.01% 1524
2021
Q3 		$716K Buy
7,112
+1,551
+28% +$160K ﹤0.01% 1451
2021
Q2 		$652K Sell
5,561
-354
-6% -$46.3K ﹤0.01% 1493
2021
Q1 		$1.12M Sell
5,915
-831
-12% -$146K ﹤0.01% 1264
2020
Q4 		$950K Buy
6,746
+3,176
+89% +$469K ﹤0.01% 1432
2020
Q3 		$585K Buy
3,570
+1,395
+64% +$248K ﹤0.01% 1517
2020
Q2 		$450K Buy
2,175
+1,242
+133% +$289K ﹤0.01% 1472
2020
Q1 		$186K Sell
933
-7,152
-88% -$1.57M ﹤0.01% 1475
2019
Q4 		$1.7M Buy
+8,085
New +$1.16M 0.01% 1370

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's MTEM Position: Q1 2022 in Review

Man Group sold out of Molecular Templates, Inc. (MTEM) in Q1 2022, closing a stake of 8,706 shares — an estimated $512K sold.

Man Group first reported a position in MTEM in Q4 2019 and held it in 9 quarters. The position peaked at $1.7M in Q4 2019. 77 funds tracked by Wall St. Rank hold MTEM as of Q1 2022.

  • Man Group reported no remaining Molecular Templates, Inc. position as of Q1 2022 after selling out during the quarter.
  • Man Group sold 8,706 Molecular Templates, Inc. shares in Q1 2022, an estimated $512K.
  • Man Group first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 9 quarters.
  • Man Group's Molecular Templates, Inc. position peaked at $1.7M in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2022.

Based on Man Group's 13F filing for Q1 2022, filed 16 May 2022.